Brachytherapy is a radiotherapeutic technique that allows the physicia
n to implant radioactive isotopes into a body cavity or directly into
tissue. Different radioisotopes have unique characteristics that the b
rachytherapist may utilize for a particular situation. The use of brac
hytherapy is part of standard radiation oncology practice in gynecolog
ical and head and neck cancer management. The prostate is approachable
for interstitial implantation due to its close proximity to the perin
eum. Over 20 years ago, primitive methods of brachytherapy were utiliz
ed in the treatment of prostate cancer. However, poor results due to i
nconsistency in achieving adequate coverage of the entire prostate and
poor patient selection caused this treatment modality to fall out of
favor. Technological advances over the last decade have restored atten
tion to brachytherapy for prostate cancer. Particularly important has
been the development of transrectal ultrasound, new radioisotopes such
as palladium-103, computer tomography, computerized dosimetry systems
, and earlier diagnosis. Modern interstitial implantation utilizing tr
ansperineal template and transrectal ultrasound guidance has resulted
in improved consistency in radiation dose delivery to the entire prost
ate. Early results are encouraging in terms of the relatively low morb
idity of the procedure, improved local control rates, and biochemical
progression free survival. This has resulted in an outpatient treatmen
t that has high patient acceptance. (C) 1997 Wiley-Liss, Inc.